BSH

Clinical Trials

Clinical studies have demonstrated the efficacy of Sodium Hyaluronate in improving dry eye symptoms, tear film stability, and ocular surface health. It is well-tolerated with a low incidence of adverse effects.

Lab Monitoring

• No specific laboratory monitoring is required for this medication due to its local action and minimal systemic absorption.

Doctor Notes

• Advise patients on proper instillation technique to avoid contamination and ensure efficacy.
• Remind patients to discard the bottle after 28 days of opening due to risk of microbial contamination.
• Can be used safely in patients with glaucoma or other ophthalmic conditions; advise to maintain a 5-10 minute interval if other eye drops are used concurrently.

Patient Guidelines

• Do not wear contact lenses while using this eye drop unless advised by a doctor; if used, wait at least 15 minutes before reinserting lenses.
• Discard bottle 28 days after opening, even if some solution remains.
• Do not share your eye drops with others to prevent cross-contamination.
• If eye irritation persists or worsens, consult an ophthalmologist.

Missed Dose Advice

If a dose is missed, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose.

Driving Precautions

May cause temporary blurred vision immediately after administration. Avoid driving or operating machinery until your vision clears and you feel safe to do so.

Lifestyle Advice

• Take regular breaks from digital screens to reduce eye strain.
• Ensure adequate hydration by drinking enough water.
• Avoid environments with dry air, smoke, or strong winds that can exacerbate dry eye symptoms.